<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) was first reported as the etiological agent of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in 1964 </plain></SENT>
<SENT sid="1" pm="."><plain>Since then, EBV has also been associated with nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, which is highly prevalent in Southeast Asia, as well as <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, <z:e sem="disease" ids="C1720105" disease_type="Disease or Syndrome" abbrv="">complications of AIDS</z:e>, and transplant-related B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This virus has further been linked with T cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, establishing the concept of a wide spectrum of EBV-associated malignant disorders </plain></SENT>
<SENT sid="3" pm="."><plain>So far, there are a number of EBV-infected cell lines established that can be induced for production of infectious <z:mp ids='MP_0001799'>viral</z:mp> progeny and that facilitate the study of the mechanism of EBV-related <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, transformation, and <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>This unit describes procedures for the preparation of EBV virion particles and in vitro <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of cells with EBV </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, procedures for quantitation and storage of the virus are provided </plain></SENT>
</text></document>